Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

1. Strategies to preventInfection control and hospital epidemiology · 2023
   Article
2. Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
   Article
3. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age.Journal of the Pediatric Infectious Diseases Society · 2022
   Article
4. Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies.Anaerobe · 2022
   Article
5. Fidaxomicin for the treatment ofFuture microbiology · 2020
   Article
6. The Role of Diagnostic Stewardship inCurrent infectious disease reports · 2020
   Article
7. An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.Journal of the Pediatric Infectious Diseases Society · 2019
   Review
8. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.Infection control and hospital epidemiology · 2019
   Article
9. Rapid molecular detection of macrolide resistance.BMC infectious diseases · 2019
   Article
10. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.Journal of pediatric gastroenterology and nutrition · 2019
    Article
11. A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers.Nature communications · 2018
    Article
12. Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
13. Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital.The Journal of antimicrobial chemotherapy · 2018
    Article
14. Advances in the diagnosis and treatment of Clostridium difficile infections.Emerging microbes & infections · 2018
    Review
15. Reducing rates ofAntimicrobial resistance and infection control · 2018
    Article

Corrections and comments

• Comment on
  Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.2017

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as